Elicio Therapeutics Inc (ELTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -80,107 | -40,658 | N/A | N/A |
| Depreciation Amortization | 8,289 | 496 | N/A | N/A |
| Accounts receivable | 440 | -333 | N/A | N/A |
| Accounts payable and accrued liabilities | -5,607 | 10,705 | N/A | N/A |
| Other Working Capital | 25,769 | 9,750 | N/A | N/A |
| Other Operating Activity | 28,328 | -4,549 | 0 | 0 |
| Operating Cash Flow | $-22,888 | $-24,589 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -41 | -242 | N/A | N/A |
| Investing Cash Flow | $-41 | $-242 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 32,118 | 5,265 | N/A | N/A |
| Common Stock Issued | 280 | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | -375 | N/A | N/A |
| Other Financing Activity | 20,011 | 0 | 0 | 0 |
| Financing Cash Flow | $52,409 | $4,890 | $N/A | $N/A |
| Exchange Rate Effect | -444 | N/A | N/A | N/A |
| Beginning Cash Position | 5,571 | 25,512 | N/A | N/A |
| End Cash Position | 34,607 | 5,571 | N/A | N/A |
| Net Cash Flow | $29,036 | $-19,941 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -22,888 | -24,589 | N/A | N/A |
| Capital Expenditure | -41 | -242 | N/A | N/A |
| Free Cash Flow | -22,929 | -24,831 | 0 | 0 |